Community Bank’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-6,000
Closed -$1.26K 439
2023
Q2
$1.26K Hold
6,000
﹤0.01% 425
2023
Q1
$900 Hold
6,000
﹤0.01% 454
2022
Q4
$3.3K Hold
6,000
﹤0.01% 437
2022
Q3
$7K Hold
6,000
﹤0.01% 426
2022
Q2
$4K Hold
6,000
﹤0.01% 401
2022
Q1
$7K Hold
6,000
﹤0.01% 394
2021
Q4
$14K Hold
6,000
﹤0.01% 369
2021
Q3
$21K Hold
6,000
﹤0.01% 353
2021
Q2
$18K Hold
6,000
﹤0.01% 365
2021
Q1
$19K Sell
6,000
-6,000
-50% -$20K ﹤0.01% 358
2020
Q4
$25K Hold
12,000
﹤0.01% 338
2020
Q3
$14K Sell
12,000
-12,000
-50% -$12.3K ﹤0.01% 368
2020
Q2
$22K Hold
24,000
﹤0.01% 344
2020
Q1
$20K Hold
24,000
﹤0.01% 309
2019
Q4
$23K Hold
24,000
﹤0.01% 320
2019
Q3
$24K Hold
24,000
﹤0.01% 307
2019
Q2
$43K Hold
24,000
0.01% 278
2019
Q1
$45K Buy
24,000
+10,000
+71% +$14.6K 0.01% 269
2018
Q4
$16K Hold
14,000
﹤0.01% 336
2018
Q3
$38K Hold
14,000
0.01% 296
2018
Q2
$27K Hold
14,000
0.01% 327
2018
Q1
$29K Buy
+14,000
New +$30K 0.01% 324

Other funds holding INFI

Community Bank's INFI Position: Q3 2023 in Review

Community Bank sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q3 2023, closing a stake of 6,000 shares — an estimated $1.26K sold.

Community Bank first reported a position in INFI in Q1 2018 and held it in 22 quarters. The position peaked at $45K in Q1 2019. 3 funds tracked by Wall St. Rank hold INFI as of Q3 2023.

  • Community Bank reported no remaining Infinity Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Community Bank sold 6,000 Infinity Pharmaceuticals, Inc. shares in Q3 2023, an estimated $1.26K.
  • Community Bank first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2018 and held it in 22 quarters.
  • Community Bank's Infinity Pharmaceuticals, Inc. position peaked at $45K in Q1 2019.
  • 3 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q3 2023.

Based on Community Bank's 13F filing for Q3 2023, filed 26 Oct 2023.